Willow Biosciences Inc T.WLLW

Alternate Symbol(s): CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.

TSX:WLLW - Post by User

Willow Biosciences Inc > webcast

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Feb 05, 2022 1:15am

121 Views

Post# 34400432

RE:RE:webcast

The whole damn industry is avoiding giving any guidance. No visibility in an industry shake out.

jermiah777 wrote: I find that discouraging since the impression left over a year ago was that Willow is transitioning to a revenue generating company. Here we are and nothing stated about revenue? How much longer can the cash hold out? Will we need to raise more money?

<< Previous

Bullboard Posts

Next >>

One of the strongest contenders to lead Canada’s cannabis market